Men's Health: Erectile Dysfunction- 5th October 2021 - 12.30pm to 1.30pm
Erectile dysfunction (ED) is defined as the inability to achieve or maintain an erection for satisfactory sexual performance. The prevalence of ED has been estimated as nearly 40% of men >40 years of age although these figures are contested. ED increases in frequency with age and is estimated to affect 15% of men aged 40–50 years, 45% of men in their 60s and 70% of men older than 70 years. Successful erection is a complex system involving reflex action (peripheral nerves and spinal cord), the limbic system (psychogenic stimuli) and the release of nitric oxide. Adequate levels of testosterone are required, and hence an intact hypothalamic/ pituitary/testicular axis. Hence, ED can result from disease or treatment that produces hormonal deficiency, neurological impairment, problems with penile blood flow, disorders of tissue mechanics, and psychologic issues.
Endothelial dysfunction is one of the first changes in CVD. ED and CVD share many common risk factors including age, hypertension, diabetes, insulin resistance, smoking, increased body mass index, cholesterol and low high-density lipoprotein, metabolic syndrome, sedentary lifestyle and depression. Numerous studies and meta-analyses have confirmed the association between ED and CAD. ED is associated with asymptomatic CAD. ED precedes CAD and referral for CAD by periods ranging from 2 to 5 years. Compared with controls, patients with ED have a higher risk for total CV events (44%), myocardial infarction (MI) (60%) and all-cause mortality (25%). ED also appears to be a marker of the severity of CVD with ED associated with increased risk of CVD mortality with a HR 1.48 in a large meta-analysis of 12 prospective cohortstudies.
There are many effective treatments.
This course is being run as an online training course. Details of how to join the meeting will be emailed to you closer to the event.
For more information please contact firstname.lastname@example.org